In Re Iris J. Davis

26 F.3d 139, 1994 U.S. App. LEXIS 22242, 1994 WL 146837
CourtCourt of Appeals for the Federal Circuit
DecidedApril 26, 1994
Docket93-1524
StatusUnpublished

This text of 26 F.3d 139 (In Re Iris J. Davis) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Iris J. Davis, 26 F.3d 139, 1994 U.S. App. LEXIS 22242, 1994 WL 146837 (Fed. Cir. 1994).

Opinion

26 F.3d 139

NOTICE: Federal Circuit Local Rule 47.6(b) states that opinions and orders which are designated as not citable as precedent shall not be employed or cited as precedent. This does not preclude assertion of issues of claim preclusion, issue preclusion, judicial estoppel, law of the case or the like based on a decision of the Court rendered in a nonprecedential opinion or order.
In re Iris J. DAVIS.

No. 93-1524.

United States Court of Appeals, Federal Circuit.

April 26, 1994.

Before NIES, PLAGER and CLEVENGER, Circuit Judges.

CLEVENGER, Circuit Judge.

Iris J. Davis appeals from the decision, on reconsideration, of the United States Patent and Trademark Office Board of Patent Appeals and Interferences (Board), affirming the rejection of claims 1-4 and 8-10 of Davis' patent application, Serial No. 911,872, as unpatentable under 35 U.S.C. Sec. 103 (1988).1 We affirm.

* The subject matter of Davis' application concerns a method of neutralizing axillary malodor--malodor present in the axillary fossae, or arm-pits--through chemical reaction with the malodor-causing compounds. Illustrative of the invention, claim 1 reads:

A method of axillary malodor neutralization comprising contacting the malodor with a malodor-reducing concentration of a sulfhydryl reactant.

In affirming the rejection of Davis' claims2 as obvious, the Board relied on three references--86 Chemical Abstracts 358, p 86:60,568b (1977) (Yamamoto); 97 Chemical Abstracts 426, p 222,753q (1982) (Tamura); and 58 Chemical Abstracts p 9547e (1963) (Lee) (collectively, the leading references)--together with a fourth reference, Cosmetics Science & Technology 1207-11 (E. Sagarin ed., 1957) (Sagarin). Yamamoto discloses a certain maleimide effective in controlling the odor produced by ammonia, amines, and various sulphur-containing compounds present in garbage piles and stables. Tamura discloses deodorants containing maleimides that control odors produced during hair wave-setting by combining with ammonia, amines, and sulfhydryl (SH)-containing compounds (thiols or mercaptans). Lee discloses use of maleimides during bread-baking to reduce the quantity of mercaptans present. Although the three leading references thus teach that maleimides3 may be used for controlling odors caused by ammonia, amines, and mercaptans in various settings, it is undisputed that the three leading references alone would not have rendered the present invention obvious to one of ordinary skill in the art, because none discloses either use of maleimides in the axillary environment or the substances responsible for axillary malodor. Thus, Sagarin's teachings are the key to the Board's holding.

Sagarin teaches, inter alia, that the human body produces two types of sweat: Eccrine sweat, resulting from the body's natural reaction to heat, and apocrine sweat, an adrenaline-induced excretion. The term "axillary sweat" thus refers not to a distinct type of sweat, but instead to sweat, whatever the makeup thereof, present in the axillary fossae.

In its original decision, the Board affirmed the rejection of the claims as unpatentable under 35 U.S.C. Sec. 103 (1988), holding that Sagarin "teaches that ... [mal]odorous sulfur and nitrogen containing compounds contribute to axillary malodor." In response to Davis' arguments based on the "Jass" affidavits, previously submitted to the examiner by Davis in an attempt to overcome the obviousness rejection, the Board stated:

It is important to note that the present claims are not specifically directed to a process involving the neutralization of the sulfhydryl moieties contained in malodor but are broadly directed to neutralizing "axillary malodor" generally by contacting the malodor ... with ... a maleimide.

On reconsideration, the Board elaborated:

Sagarin teaches that genuine apocrine sweat (axillary sweat) contains a considerable amount of odor producing materials including protein derivatives. Protein derivatives obviously contain nitrogen moieties and more than likely also contain sulfur moieties. We also note that Sagarin teaches that apocrine sweat contains high concentrations of ammonia.... [Thus,] ... Sagarin fairly teaches that sulfur and/or nitrogen containing materials contribute to body malodor in axillary sweat. (citation omitted). Dissatisfied with the Board's opinion, Davis timely appealed to this court.

II

This court reviews an obviousness determination by the Board de novo, while reviewing any factual findings underlying the obviousness determination for clear error. In re Woodruff, 919 F.2d 1575, 1577, 16 USPQ2d 1934, 1935 (Fed.Cir.1990); see Minnesota Mining & Mfg. Co. v. Johnson & Johnson Orthopaedics, Inc., 976 F.2d 1559, 1572-73, 24 USPQ2d 1321, 1332-33 (Fed.Cir.1992) (scope and content of prior art, and differences between prior art and claimed invention, are questions of fact).

Davis alleges several errors in the Board's determination of what Sagarin teaches to one of ordinary skill in the art. Specifically, Davis argues, inter alia, that the Board erred in finding that Sagarin teaches the presence of odor-causing amounts of sulfur moieties, specifically thiols, the odor of which would be neutralized through reaction with sulfhydryl reactants. In response, the Board presents the following argument: "protein derivatives" come from proteins; proteins include amino acids; one of the frequently occurring amino acids is cysteine; cysteine includes a sulfhydryl group; and therefore protein derivatives must include malodorous sulfhydryl-containing compounds.

This argument in support of the Board's rejection is simply too attenuated to provide a sound basis for an obviousness rejection. Nothing in Sagarin teaches that the "protein derivatives" present in apocrine sweat must include malodorous, sulfur-containing compounds. Moreover, the Board's language on reconsideration that "[p]rotein derivatives ... more than likely also contain sulfur moieties" (emphasis added) is speculative and therefore insufficient to support the rejection. In re Rijckaert, 9 F.3d 1531, 1533 n. 3, 28 USPQ2d 1955, 1957 n. 3 (Fed.Cir.1993) (Board's language that limitation was "probably satisfied" by prior art "is speculative and therefore does not establish a prima facie case of unpatentability.").

That Sagarin does not teach the presence of malodorous sulfur compounds in human sweat, however, does not dispose of this case. The Board also found that Sagarin teaches the presence of malodorous nitrogenous compounds, including ammonia, in axillary sweat.4 Since maleimides readily combine with such compounds to reduce the odor caused thereby, as disclosed by the three leading references, such a finding, unless clearly erroneous, would provide a basis for upholding the Board's conclusion of obviousness.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Berwyn E. Etter
756 F.2d 852 (Federal Circuit, 1985)
In Re Donald H. Thorpe
777 F.2d 695 (Federal Circuit, 1985)
In Re William J. King
801 F.2d 1324 (Federal Circuit, 1986)
In Re Alex Zletz
893 F.2d 319 (Federal Circuit, 1990)
In Re Richard E. Woodruff
919 F.2d 1575 (Federal Circuit, 1990)
In re Wesslau
353 F.2d 238 (Customs and Patent Appeals, 1965)
In re Mercier
515 F.2d 1161 (Customs and Patent Appeals, 1975)

Cite This Page — Counsel Stack

Bluebook (online)
26 F.3d 139, 1994 U.S. App. LEXIS 22242, 1994 WL 146837, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-iris-j-davis-cafc-1994.